Baxter International Inc.

$19.38 ▲ 0.15%
2026-06-06 06:44:00

Explore Baxter International Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.

Market Cap
$10 B
Current Price
$19.38
52W High / Low
$32.04 / $15.73
Stock P/E
Book Value
$11.92
Dividend Yield
0.21%
ROCE
1.04%
ROE
-16.43%
Face Value
EPS
$-2.14
Exp Qtr EPS
Sector
Healthcare

BAX — Monthly Price History

Adjusted close price  ·  Hover to see price & month

Pros

  • Short-term liquidity looks comfortable.
  • Valuation is not stretched on P/E basis.
  • Meaningful dividend yield is available.

Cons

  • Return on equity is on the weaker side.
  • Capital efficiency is modest.
  • Leverage is relatively high.
  • Operating margin is thin.
  • Net margin is relatively low.

Sift Stocks

S.No. Name Price P.E. Market Cap Div Yld % ROCE ROE 52Week High/ Low Book Value
1. Intuitive Surgical, Inc. $422.06 50.54 $150.56 B 15.96% 16.98% $603.88 / $396.68 $50.19
2. Becton, Dickinson and Company $151.16 36.88 $41.96 B 2.81% 6.35% 4.54% $187.35 / $127.59 $88.96
3. ResMed Inc. $196.04 18.64 $28.33 B 1.24% 23.58% 24.41% $293.81 / $180.26 $40.77
4. Alcon Inc. $66.81 40.34 $26.02 B 0.01% 4.77% 3.71% $74.34 / $47.8 $45.21
5. West Pharmaceutical Services, Inc. $314.5 41.18 $22.35 B 0.33% 17.6% 17.87% $330.88 / $206.8 $44.11
6. Hologic, Inc. $0 31.2 $16.97 B 9.77% 11.01% $76.07 / $61.28 $22.68
7. Solventum Corporation $81.01 9.8 $14.03 B 5.66% 30.71% $88.2 / $62.38 $29.1

Quarterly Results

Figures shown in M / B

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Sales2.97 B2.83 B2.81 B2.62 B2.75 B
Operating Profit-244 M172 M191 M58 M-1 M
Net Profit-1.13 B-46 M91 M126 M-512 M
EPS in Rs-2.18-0.090.180.24-0.99

Profit & Loss

Figures shown in M / B

2025202420232022
Sales11.24 B10.64 B10.36 B10.06 B
Operating Profit177 M439 M707 M-33 M
Net Profit-957 M-649 M2.66 B-2.43 B
EPS in Rs-1.85-1.265.14-4.71

Balance Sheet

Figures shown in M / B

2025202420232022
Total Assets20.05 B25.78 B28.28 B28.29 B
Total Liabilities13.95 B18.76 B19.81 B22.39 B
Equity6.13 B6.96 B8.4 B5.83 B
Current Assets6.87 B8.85 B9.6 B8.01 B
Current Liabilities2.97 B6.51 B6.5 B4.75 B

Cash Flow

Last available yearly cash flow history

2025202420232022
Operating CF845 M1.02 B1.73 B1.21 B
Investing CF2.84 B-626 M3.21 B-931 M
Financing CF-4.22 B-1.08 B-3.49 B-1.44 B
Free CF323 M559 M1.29 B576 M
Capex-522 M-460 M-436 M-635 M

5Y Margin & Growth History

Last 5 years of annual financial statement data.

2024202320222021
Revenue Growth %2.66%3.01%
Earnings Growth %-124.44%209.17%
Profit Margin %-6.1%25.64%-24.19%
Operating Margin %4.13%6.82%-0.33%
Gross Margin %37.46%40.06%35.29%
EBITDA Margin %10.49%16.74%-17.53%

Dividend & Split History

Latest dividend payments and stock split events.

Dividend History

Ex DateDividend
2026-02-27$0.01
2025-11-28$0.01
2025-08-29$0.17
2025-05-30$0.17
2025-02-28$0.17
2024-11-29$0.17
2024-08-30$0.29
2024-05-31$0.29
2024-02-29$0.29
2023-11-30$0.29
2023-08-31$0.29
2023-06-01$0.29
2023-02-23$0.29
2022-12-01$0.29
2022-09-01$0.29
2022-06-02$0.29
2022-02-24$0.28
2021-12-02$0.28
2021-09-02$0.28
2021-06-03$0.28

Stock Splits

No stock split history available.

Shareholding Pattern

Shares and value shown in M / B

Holder Name Type Shares Value % Out Report Date
Fidelity Hastings Street Trust-Fidelity Series Large Cap Stock Fund Mutual Fund 6.92 M $115.46 M 0.01% 2026-02-28
BLACKROCK EQUITY DIVIDEND FUND Mutual Fund 20.35 M $339.46 M 0.04% 2026-01-31
VANGUARD WINDSOR FUNDS-Vanguard Windsor Fund Mutual Fund 10.44 M $174.13 M 0.02% 2026-01-31
Invesco Exchange-Traded Fund Trust-Invesco S&P 500 Equal Weight ETF Mutual Fund 8.73 M $145.61 M 0.02% 2026-01-31
iShares Trust-iShares Core S&P 500 ETF Mutual Fund 6.61 M $110.34 M 0.01% 2026-01-31
Blackrock Inc. Institutional 84.78 M $1.41 B 0.16% 2025-12-31
Pzena Investment Management LLC Institutional 70.05 M $1.17 B 0.14% 2025-12-31
Vanguard Group Inc Institutional 62.64 M $1.04 B 0.12% 2025-12-31
Dodge & Cox Inc. Institutional 57 M $950.76 M 0.11% 2025-12-31
Dodge & Cox Funds-Dodge & Cox Stock Fund Mutual Fund 38.62 M $644.24 M 0.07% 2025-12-31
FMR, LLC Institutional 34.81 M $580.66 M 0.07% 2025-12-31
State Street Corporation Institutional 22.54 M $375.95 M 0.04% 2025-12-31
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund Mutual Fund 16.21 M $270.31 M 0.03% 2025-12-31
Geode Capital Management, LLC Institutional 13.51 M $225.35 M 0.03% 2025-12-31
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund Mutual Fund 12.95 M $216.07 M 0.03% 2025-12-31

Frequently Asked Questions — Baxter International Inc.

Will Baxter International Inc. stock hit $23 in 2026?

Baxter International Inc. (BAX) is currently trading at $19.38, with a 52-week range of $15.73 to $32.04. Reaching the $23 level would represent a 20% gain from the current price — a target many investors consider when evaluating near-term upside potential.

Wall Street analysts currently have a consensus price target of $22.12 for Baxter International Inc., with a Hold rating, and the most bullish analysts see the stock reaching as high as $40.0. Whether Baxter International Inc. can reach $23 in 2026 depends on several factors: revenue and earnings growth trajectory, broader market conditions, sector sentiment within the Healthcare space, and any company-specific catalysts such as product launches, earnings beats, or strategic announcements.

Historically, BAX has delivered a -24.8% CAGR over the past 5 years, which suggests the stock has demonstrated meaningful long-term growth momentum. However, past performance does not guarantee future results, and short-term price movements can be influenced by macroeconomic shifts, interest rate changes, and investor sentiment. Use the BAX Stock Return Calculator on StockSifting to model different growth scenarios and see how various CAGR assumptions translate to potential price targets. This content is for informational purposes only and does not constitute financial advice.

Is Baxter International Inc. stock worth buying at $19.38?

Whether Baxter International Inc. (BAX) is worth buying at $19.38 depends on your investment goals, time horizon, and risk tolerance. Here is a breakdown of the key metrics investors typically evaluate:

Valuation: Valuation data is currently limited — check the full ratios section on StockSifting for the latest P/E, P/B, and EV/EBITDA figures.

Profitability & efficiency: Baxter International Inc. has a Return on Capital Employed (ROCE) of 1.0%, which reflects modest capital efficiency. Its Return on Equity (ROE) stands at -16.4%.

Financial health: The Debt-to-Equity ratio of 160.28 indicates a higher degree of financial leverage — investors should monitor debt servicing capacity.

Analyst view: The Wall Street consensus recommendation for BAX is currently Hold, with a mean price target of $22.12 based on 13 analyst ratings. Always conduct your own due diligence and consider consulting a qualified financial advisor before making any investment decisions. Nothing on StockSifting constitutes financial advice.

What is the analyst price target for Baxter International Inc. (BAX) in 2026?

As of 2026, Wall Street analysts have set a consensus (mean) price target of $22.12 for Baxter International Inc. (BAX), aggregated from 13 analyst ratings. The overall analyst recommendation is Hold.

The price target range spans from $17.0 on the bearish end to $40.0 on the most optimistic projection, with a median target of $20.0. This wide range reflects differing views on Baxter International Inc.'s growth prospects, competitive positioning, and macroeconomic sensitivity.

It is important to note that analyst price targets are forward-looking estimates based on financial models, earnings projections, and sector assumptions — they are not guarantees. Targets are regularly revised following quarterly earnings results, management guidance updates, or shifts in the broader economic outlook. Stocks can trade significantly above or below analyst targets depending on market conditions. View the full analyst breakdown and track target revisions on the BAX analysis page on StockSifting.

How much can you earn by reinvesting Baxter International Inc. dividends?

Dividend reinvestment — commonly known as DRIP (Dividend Reinvestment Plan) — is a powerful wealth-building strategy where instead of receiving your dividend payouts as cash, the dividends are automatically used to purchase additional shares of Baxter International Inc. (BAX). Over time, this creates a compounding effect: more shares generate more dividends, which buy even more shares.

Baxter International Inc. currently offers a dividend yield of approximately 21.00%. While this may seem modest in isolation, the real power of DRIP emerges over long holding periods. An investor who reinvested dividends consistently over 10–20 years would accumulate significantly more shares than one who took dividends as cash — and those extra shares continue generating their own dividend income.

The key variables that determine your DRIP returns are: your initial investment amount, the number of years you stay invested, the dividend yield at the time of each reinvestment, and whether Baxter International Inc. grows or cuts its dividend over time. Market price appreciation of BAX also plays a significant role — rising share prices increase the value of your accumulated shares.

Use the BAX DRIP Calculator on StockSifting to enter your investment amount, start date, and contribution frequency — and see a year-by-year breakdown of shares accumulated, dividends earned, and total portfolio value. Past dividend payments are not a guarantee of future payouts. This is not financial advice.